Create your account

Analyse episodes, create alerts, spot trends before they go mainstream

Already have an account? Sign in

Companies

Merck

Mentioned in 22 analyzed podcast episodes across 10 shows

A major multinational pharmaceutical company discussed across podcasts for its extensive drug portfolio spanning osteoporosis, vaccines, cardiology, and GLP-1 treatments, as well as its involvement in peptide and gene regulatory network research. Podcast mentions focus on its business practices including patent cliff vulnerabilities, pricing pressures from pharmacy benefit managers and government programs, vaccine liability models, and regulatory relationships. The company also manufactures ivermectin and has invested in AI-driven drug discovery platforms.

Episode Mentions

Mad Money w/ Jim Cramer

Mad Money w/ Jim Cramer · Apr 7, 2026

'Mad Money w/ Jim Cramer 4/7/26

Pharmaceutical company down 1.3%; drug stocks declining as inflation concerns rise

Market Technical Analysis and Moving AveragesConsumer Spending Patterns and Economic SlowdownRetail Sector Performance and Competitive Dynamics
View Analysis
TBPN

TBPN · Mar 31, 2026

Is Meta Really Addictive?, Jetsons Prediction, Artemis II: Back to the Moon | Diet TBPN

Previous target of attorney Mark Lanier in successful Vioxx wrongful death lawsuit

Social Media Addiction LawsuitsPlatform Design vs Content LiabilitySection 230 Legal Strategy
View Analysis
TBPN

TBPN · Mar 23, 2026

The Great Peptide Debate with Martin Shkreli & Max Marchione

Pharmaceutical giant cited as example of established drug companies Martin advocates for

Peptide regulation and FDA oversightBPC-157 safety and efficacy debateGLP-1 receptor agonists
View Analysis
Adam Carolla Show

Adam Carolla Show · Mar 3, 2026

Why the Government Lied about COVID w/ Gavin de Becker

Former CDC director Julie Gerberding became president of Merck vaccine division after leaving government, exemplifying regulatory capture

COVID-19 Lockdown Policy EffectivenessGovernment Narrative Control and DisinformationVaccine Safety and Long-Term Testing Protocols
View Analysis
Danny Jones Podcast

Danny Jones Podcast · Feb 27, 2026

#374 - Ex-Pharma Insider Exposes the $368 Billion Health Insurance Scam | Brigham Buhler

Made Fosamax osteoporosis drug; benefited from Women's Health Initiative scare campaign against estrogen

Pharmacy Benefit Manager (PBM) Rebate Schemes and Price ManipulationInsurance Company Conflicts of Interest and Vertical IntegrationFDA Regulatory Capture and Revolving Door with Pharma
View Analysis
Mind Pump: Raw Fitness Truth

Mind Pump: Raw Fitness Truth · Feb 26, 2026

2802: The State of the Hormone & Peptide Industry w/ Vita Bella Founder Phil Vella

Pharma company developing myostatin inhibitors and advancing clinical trials for peptide combinations with GLP-1s

Peptide pricing transparency and cost structure analysisQuality control and third-party testing in gray-market peptidesGLP-1 monotherapy risks and combination protocol design
View Analysis
Marketplace

Marketplace · Feb 17, 2026

Why would the Fed loosen mortgage regulations?

Pharmaceutical company operating in vaccine development sector impacted by regulatory and funding changes

Federal Reserve Mortgage Regulation ReformBank Capital Requirements and Mortgage LendingNon-Bank Mortgage Origination Market Share
View Analysis
Culture Apothecary with Alex Clark

Culture Apothecary with Alex Clark · Feb 17, 2026

Cancer, Cover-Ups & Chemical Immunity: Inside the Monsanto Papers with R. Brent Wisner, Esq

Vaccine manufacturer with liability immunity model that pesticide companies are attempting to replicate through federal preemption

Glyphosate health effects and cancer causationMonsanto internal documents and cover-up evidenceEPA regulatory capture and corruption
View Analysis
The Jesse Kelly Show

The Jesse Kelly Show · Feb 11, 2026

GOP Takes HUGE Step Toward Accountability in Jack Smith Arctic Frost Probe

Pharmaceutical company funding the American Academy of Pediatrics vaccine schedule decisions

Jack Smith Special Counsel Investigation and DOJ WeaponizationIllegal Immigrant Census Counting and Congressional ApportionmentTransgender Medical Procedures for Minors (SAFE Act)
View Analysis
unPAUSED with Dr. Mary Claire Haver

unPAUSED with Dr. Mary Claire Haver · Feb 10, 2026

Female Libido in Menopause: Desire Loss, Biology & Solutions with Cindy Eckert

Eckert's first employer post-college; she worked in pharmaceutical sales and learned foundational industry knowledge before launching startups.

Female sexual desire disorder (HSDD) biology and neurotransmitter mechanismsFDA approval process and regulatory standards for women's sexual health medicationsPhysician education gaps in women's sexual health training
View Analysis
CNBC's "Fast Money"

CNBC's "Fast Money" · Feb 6, 2026

Mini Correction or Fundamental Rethinking?… And Bitcoin Bounces Back After Plunge 2/6/26

Pharma company with 40-50% patent cliff exposure; most vulnerable to upcoming patent expirations among major players.

AI CapEx Spending SustainabilitySoftware Stock Valuation and Disruption RiskMarket Rotation: Growth to Value/Cyclicals
View Analysis
This Week in Cardiology

This Week in Cardiology · Feb 6, 2026

Feb 06 2026 This Week in Cardiology

Sponsoring enlicitide (oral PCSK9 inhibitor) with planned Coral Reef Outcomes Trial completion in December 2029

PREVENT Risk Score Validation and Racial DisparitiesOral PCSK9 Inhibitors (Enlicitide)Factor XI Inhibition in Stroke Prevention
View Analysis
Mad Money w/ Jim Cramer

Mad Money w/ Jim Cramer · Feb 5, 2026

Mad Money w/ Jim Cramer 2/4/26

Profitable pharmaceutical company with strong earnings and dividend; competing in GLP-1 market

GLP-1 Drug Competition and Pricing StrategyEnterprise Software Industry Disruption by AIMarket Rotation from Growth to Value Stocks
View Analysis
Congressional Dish

Congressional Dish · Jan 31, 2026

CD331: December 2025 — Authorizing Future Disasters

USDA nominee Mindy Brasher consulted for Merck animal drugs division before appointment to food safety position

Aviation Safety Regulation and Mid-Air Collision PreventionNational Defense Authorization Act (NDAA) Provisions and LoopholesEnvironmental Deregulation and Federal Land Protection
View Analysis
Tetragrammaton with Rick Rubin

Tetragrammaton with Rick Rubin · Jan 28, 2026

Dr. Mary Talley Bowden

Manufacturer of ivermectin; Dr. Bowden reviewed FDA toxicity data from Merck's approval submission

Direct Specialty Care and Cash-Only Medical PracticesCOVID-19 Early Treatment Protocols (Ivermectin, Monoclonal Antibodies)Sleep Apnea Diagnosis and Treatment (CPAP, Home Testing, Surgical Alternatives)
View Analysis
The Al Franken Podcast

The Al Franken Podcast · Jan 25, 2026

Wendell Potter on The Healthcare Crisis

Pharmaceutical company subject to PBM rebate demands; example of drug maker forced to pay kickbacks to PBMs for formulary placement

Prior Authorization Denials and Patient HarmMedical Loss Ratio Circumvention StrategiesPharmacy Benefit Manager Market Consolidation
View Analysis
All-In with Chamath, Jason, Sacks & Friedberg

All-In with Chamath, Jason, Sacks & Friedberg · Jan 9, 2026

Howard Lutnick: How America Can Hit 6% GDP Growth in 2026

Pharmaceutical company that committed to providing top drug to Medicaid/Medicare for zero cost under MFN pricing initiative

Tariff Strategy and Trade RebalancingPharmaceutical Price Controls and MFN PricingSemiconductor Manufacturing and CHIPS Act Reform
View Analysis
The a16z Show

The a16z Show · Jan 2, 2026

Wartime vs Peacetime: Ben Horowitz on Leadership

Wartime vs Peacetime LeadershipCompany CultureHealthcare Innovation
View Analysis
DarkHorse Podcast

DarkHorse Podcast · Dec 24, 2025

Hey Siri, why are American kids so sick? Aaron Siri on DarkHorse

Vaccine manufacturer; discussed in context of industry consolidation from 6 manufacturers in 1986 to single manufacturers per vaccine

Vaccine Safety Testing Methodology and Placebo ControlsChildhood Vaccine Schedule Expansion and Chronic Disease CorrelationManufacturer Liability Immunity Under 1986 National Childhood Vaccine Injury Act
View Analysis
BG2Pod with Brad Gerstner and Bill Gurley

BG2Pod with Brad Gerstner and Bill Gurley · Dec 23, 2025

AI Enterprise - Databricks & Glean | BG2 Guest Interview

Customer example: created TEDDY (Transformer Enabled Drug Discovery) model for gene regulatory network analysis and drug discovery applications

Enterprise AI adoption and deployment challengesLLM commoditization and competitive differentiationProprietary data as competitive moat in AI
View Analysis
Lex Fridman Podcast

Lex Fridman Podcast · Sep 19, 2025

#481 – Norman Ohler: Hitler, Nazis, Drugs, WW2, Blitzkrieg, LSD, MKUltra & CIA

German pharmaceutical company that produced Eukodal (oxycodone), Hitler's preferred opioid injection drug administered daily by Dr. Morell

Nazi Germany Drug Use and Military StrategyMethamphetamine (Pervitin) in Wehrmacht OperationsHitler's Opioid Addiction and Decision-Making Decline
View Analysis
The Resetter Podcast with Dr. Mindy

The Resetter Podcast with Dr. Mindy · Sep 1, 2025

Considering HRT? A Natural, Informed & Safe Approach with Dr. Nasha Winters

Manufacturer of NuvaRing; case study of Erica Langhart's death from blood clots led to $100M settlement

Hormone Replacement Therapy (HRT) safety and appropriate candidacySingle Nucleotide Polymorphisms (SNPs) and genetic testing for hormone metabolismFunctional medicine approach to perimenopause and menopause
View Analysis